Insurance Denials Keep Life-Saving Treatments Out of Reach as Reform Pledges Stall

For Sheldon Ekirch, a 31-year-old woman from Henrico, Virginia, living with small-fiber neuropathy — a painful condition causing a burning sensation throughout her limbs — the battle for insurance coverage consumed two years of her life. Her insurer, Anthem Blue Cross and Blue Shield, repeatedly denied coverage for intravenous immunoglobulin (IVIG) infusions, a blood plasma treatment costing approximately $10,000 per session that her doctors recommended to manage her symptoms. To keep her alive and functional, her parents withdrew around $90,000 from her father's retirement savings. The situation changed in February when an external review conducted for the Virginia Bureau of Insurance overturned Anthem's denial, reducing her family to tears of relief. An Anthem spokesperson acknowledged the reversal, stating the company respects the external reviewer's decision, though it maintained the treatment did not align with its internal evidence-based standards. Ekirch's experience is far from isolated. Millions of Americans annually navigate the prior authorization process, a system requiring patients or physicians to obtain insurer approval before proceeding with prescribed care. Despite a pledge made by major health insurance companies last June to streamline prior authorizations — including faster response times and clearer denial explanations — follow-through has been limited. When contacted, roughly half of the insurers that signed the pledge could not provide specific details about services they had removed from prior authorization requirements. Patient advocates and medical professionals remain deeply skeptical. The president of the American Medical Association noted that insurers made similar commitments in 2018 with little meaningful result, and that the current process remains costly, inefficient, and hazardous for patients. A recent health policy poll found that 39% of patients with chronic conditions consider prior authorization the single greatest barrier to receiving care. For Ekirch, even the hard-won victory is temporary — her current insurance coverage expires in late March, forcing her to face the prior authorization process all over again with a new plan.